LAB-OMICS AND PROGNOSTIC MARKERS

Autor: R. L. Jensen, S. Abraham, N. Hu, J.-L. Boulay, S. Leu, S. Frank, E. Vassella, I. Vajtai, S. von Felten, E. Taylor, M. Schulz, G. Hutter, M. Sailer, J. Hench, L. Mariani, H. F. van Thuijl, I. Scheinin, D. F. van Essen, J. J. Heimans, P. Wesseling, B. Ylstra, J. C. Reijneveld, A. R. Borges, P. L. Larrubia, J. M. B. Marques, S. G. Cerdan, P. Brastianos, P. Horowitz, S. Santagata, R. T. Jones, A. McKenna, G. Getz, K. Ligon, E. Palescandolo, P. Van Hummelen, A. Stemmer-Rachamimov, D. Louis, W. C. Hahn, I. Dunn, R. Beroukhim, X. Guan, J. Vengoechea, S. Zheng, A. Sloan, Y. Chen, D. Brat, B. P. O'Neill, M. Cohen, K. Aldape, S. Rosenfeld, H. Noushmehr, R. G. Verhaak, J. Barnholtz-Sloan, E. M. Bahassi, Y.-Q. Li, E. Cross, W. Li, J. Vijg, C. McPherson, R. Warnick, P. Stambrook, O. Rixe, L. Manterola, S. Tejada-Solis, R. Diez-Valle, M. Gonzalez, P. Jauregui, N. Sampron, C. Barrena, I. Ruiz, J. Gallego, J.-Y. Delattre, A. L. de Munain, M. M. Mlonso, K. Saito, A. Mukasa, G. Nagae, K. Aihara, S. Takayanagi, H. Aburatani, N. Saito, X.-T. Kong, B. D. Fu, S. Du, A. N. Hasso, M. E. Linskey, D. Bota, C. Li, Y.-S. Chen, Z.-p. Chen, C. H. Kim, J. H. Cheong, J. M. Kim, N. P. Yelon, E. Jacoby, Z. R. Cohen, J. Ishida, K. Kurozumi, T. Ichikawa, M. Onishi, K. Fujii, Y. Shimazu, I. Date, R. Narayanan, Q. H. Ho, B. S. Levin, M. L. Maeder, J. K. Joung, C. L. Nutt, D. N. Louis, J. Thorsteinsdottir, P. Fu, M. Gehrmann, G. Multhoff, J.-C. Tonn, C. Schichor, K. Thirumoorthy, N. Gordon, S. Walston, D. Patel, M. Okamoto, A. Chakravarti, K. Palanichamy, P. French, L. Erdem, L. Gravendeel, J. de Rooi, P. Eilers, A. Idbaih, W. Spliet, W. den Dunnen, J. Teepen, P. S. Smitt, J. M. Kros, T. Gorlia, M. van den Bent, D. McCarthy, R. W. Cook, K. Oelschlager, D. Maetzold, M. Hanna, W. Wick, C. Meisner, B. Hentschel, M. Platten, M. C. Sabel, S. Koeppen, R. Ketter, M. Weiler, G. Tabatabai, A. Schilling, A. von Deimling, D. Gramatzki, M. Westphal, G. Schackert, M. Loeffler, M. Simon, G. Reifenberger, M. Weller, L. Moren, M. Johansson, T. Bergenheim, H. Antti, E. P. Sulman, L. D. Goodman, K. M. Wani, F. DeMonte, K. D. Aldape, B. Krischek, I. Gugel, D. Aref, C. Marshall, S. Croul, G. Zadeh, C. L. Nilsson, E. Sulman, H. Liu, C. Wild, C. F. Lichti, M. R. Emmett, F. F. Lang, C. Conrad, A. Alentorn, Y. Marie, B. Boisselier, C. Carpetier, K. Mokhtari, K. Hoang-Xuan, L. Capelle, T. Lautenschlaeger, A. Huebner, J. B. McIntyre, T. Magliocco, M. Hamilton, J. Easaw, B. Pollo, C. Calatozzolo, R. Vuono, S. Guzzetti, M. Eoli, A. Silvani, F. Di Meco, G. Filippini, G. Finocchiaro, A. Joy, A. Ramesh, I. Smirnov, M. Reiser, W. Shapiro, G. Mills, S. Kim, B. Feuerstein, D. D. Gonda, J. Li, N. McCabe, S. Walker, N. Goffard, K. Wikstrom, E. McLean, C. Greenan, T. Delaney, M. McCarthy, F. McDyer, K. E. Keating, I. F. James, T. Harrison, P. Mullan, D. P. Harkin, B. S. Carter, R. D. Kennedy, C. C. Chen, A. S. Patel, J. E. Allen, D. T. Dicker, K. Rizzo, J. M. Sheehan, M. J. Glantz, W. S. El-Deiry, B. Salhia, J. T. Ross, J. Kiefer, C. Van Cott, R. Metpally, A. Baker, Z. Sibenaller, S. Nasser, T. Ryken, R. Ramanathan, M. E. Berens, J. Carpten, N. L. Tran, Y. Bi, S. Pal, Z. Zhang, R. Gupta, L. Macyszyn, H. Fetting, D. O'Rourke, R. V. Davuluri, A. M. Ezrin, K. Moore, W. Stummer, C. G. Hadjipanayis, D. P. Cahill, J. Beiko, D. Suki, S. Prabhu, J. Weinberg, F. Lang, R. Sawaya, G. Rao, I. McCutcheon, F. G. Barker, A. D. Trister, B. Bot, K. Fontes, C. Bridge, A. L. Baldock, J. K. Rockhill, M. M. Mrugala, R. R. Rockne, E. Huang, K. R. Swanson, H. R. Underhill, J. Zhang, M. Shi, X. Lin, A. Mikheev, R. C. Rostomily, A. C. Scheck, P. Stafford, A. Hughes, Z. Cichacz, S. W. Coons, S. A. Johnston, L. Mainwaring, J. Craig, D. Garcia, G. Bergthold, M. Burns, B. Rich, S. Ramkissoon, C. Eberhart, A. Ligon, L. Goumnerova, C. Stiles, M. Kieran, W. Hahn, K. H. Olausson, J. Correia, E. Gafni, M. Theisen, M. Hayashi, S. Haidar, C. Maire, L. A. Mainwaring, A. Norden, P. Wen, A. Kung, B. Alexander, P. Tonellato, K. L. Ligon

Publikováno v: Neuro-Oncology. 14:vi91-vi100

High-grade glioma is the most common brain tumor in adults, and the prognosis for patients diagnosed with this type of cancer is still poor. The biological behavior of the tumors is correlated to t ...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eeeb63c14ad969cab023751e0b7ab83
https://doi.org/10.1093/neuonc/nos231

P1208 PREDICTION OF SEVERE CUTANEOUS REACTION DURING TRIPLE THERAPY IN HCV: VALIDATION OF A GWAS CANDIDATE GENETIC MARKER

Autor: Ralph DeMasi, I. Lonjon-Domanec, H. Wedemeyer, María Isabel Colombo, E. Palescandolo, Jeroen Aerssens, L. Vijgen, Alessandra Mangia, Willem Talloen

Publikováno v: Journal of Hepatology. 60:S490-S491

of response (28.9%), personal reasons (29.6%), adverse events (AEs, 38.2%), decompensation (1.3%). 263/500 (52.6%) obtained a sustained virological response (SVR), 71 (14.2%) relapsed and 61 (12.2%) were non-responders. Treatment outcome information

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e1a13ec6e71e6d475d13646127112a91
https://doi.org/10.1016/s0168-8278(14)61368-4

DN-p73 is activated after DNA damage in a p53-dependent manner to regulate p53-induced cell cycle arrest

Autor: Massimo Levrero, Natalia Pediconi, Stefania Vossio, Francesca Moretti, E. Palescandolo, Clara Balsano, Antonio Costanzo

Publikováno v: Oncogene. 21(23)

p53 and p73 genes are both activated in response to DNA damage to induce either cell cycle arrest or apoptosis, depending on the strength and the quality of the damaging stimulus. p53/p73 transcriptional activity must be tightly regulated to ensure t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b84cf8a28005e82f0a5b1f1860638948
https://pubmed.ncbi.nlm.nih.gov/12032848

840 DNP73 regulates NFKB-dependent proliferation and counteracts P53 and TAP73-induced growth arrest of hepatocytes

Autor: Massimo Levrero, Stefania Vossio, Francesca Moretti, Marcella Fulco, Antonio Costanzo, E. Palescandolo

Publikováno v: Hepatology. 38:566-567

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c96959dff723c488afb1f964207fbccf
https://doi.org/10.1016/s0270-9139(03)80882-0

83 DNP73 IS A DIRECT TARGET GENE OF BOTH GAIN-OF-FUNCTION BETA-CATENIN MUTANTS AND WILD-TYPE DEREGULATED BETA-CATENIN AND COUPLES WNT PATHWAY ACTIVATION TO CHEMIORESISTANCE IN HUMAN HCC

Autor: Massimo Levrero, E. Palescandolo, Barbara Testoni, R. De Iaco, Stefania Vossio, V. Schinzari

Publikováno v: Journal of Hepatology. 48:S36

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ca1120b6b3510aac66ddd7e63f8b5274
https://doi.org/10.1016/s0168-8278(08)60085-9